Premium
An unusual case of Lafora body disease
Author(s) -
Corkill Robin G.,
Hardie Richard J.
Publication year - 1999
Publication title -
european journal of neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.881
H-Index - 124
eISSN - 1468-1331
pISSN - 1351-5101
DOI - 10.1111/j.1468-1331.1999.tb00021.x
Subject(s) - carbamazepine , medicine , lafora disease , status epilepticus , valproic acid , disease , dermatology , epilepsy , pediatrics , psychiatry , biochemistry , chemistry , phosphorylation , phosphatase
A case is described in which non‐convulsive status epilepticus (NCSE) prompted further investigation leading to the diagnosis of Lafora body disease (LBD). The onset of NCSE was temporally related to the withdrawal of sodium valproate and introduction of carbamazepine, which may have been precipitating factors. NCSE has not previously been reported in LBD. Implications for its drug management are discussed.